JP2011522553A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011522553A5 JP2011522553A5 JP2011512983A JP2011512983A JP2011522553A5 JP 2011522553 A5 JP2011522553 A5 JP 2011522553A5 JP 2011512983 A JP2011512983 A JP 2011512983A JP 2011512983 A JP2011512983 A JP 2011512983A JP 2011522553 A5 JP2011522553 A5 JP 2011522553A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- growth factor
- interleukin
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08010651 | 2008-06-11 | ||
| EP08010651.1 | 2008-06-11 | ||
| PCT/EP2009/057232 WO2009150199A1 (en) | 2008-06-11 | 2009-06-11 | Conditioned medium of liver progenitor cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011522553A JP2011522553A (ja) | 2011-08-04 |
| JP2011522553A5 true JP2011522553A5 (cg-RX-API-DMAC7.html) | 2012-07-12 |
| JP5632833B2 JP5632833B2 (ja) | 2014-11-26 |
Family
ID=40905279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011512983A Expired - Fee Related JP5632833B2 (ja) | 2008-06-11 | 2009-06-11 | 肝臓前駆細胞の馴化培地 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10456425B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2296672B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5632833B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN102119031B (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0909866B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2727392C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2296672T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2556630T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE028676T2 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2296672T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2296672E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009150199A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2333047A1 (en) * | 2009-12-09 | 2011-06-15 | Fresenius Medical Care Deutschland GmbH | Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease |
| US8603470B1 (en) | 2012-08-07 | 2013-12-10 | National Cheng Kung University | Use of IL-20 antagonists for treating liver diseases |
| JP6474394B2 (ja) * | 2013-07-05 | 2019-02-27 | ユニベルシテ カトリック ドゥ ルーベン | ヒト成体肝臓幹細胞由来の馴化培地および肝臓障害の治療におけるその使用 |
| BR112016004911A2 (pt) | 2013-09-05 | 2017-09-05 | Inis Biotech Llc | Proteína secretada, acídica e rica em cisteína, um novo alvo para o tratamento e prevenção de insuficiência aguda do fígado |
| RU2644650C2 (ru) | 2014-12-01 | 2018-02-13 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток и способ его получения |
| CN104818245B (zh) * | 2015-05-29 | 2020-02-04 | 广州赛莱拉干细胞科技股份有限公司 | 一种肝脏干细胞的培养基及培养方法 |
| EP3414319B1 (en) | 2016-02-10 | 2024-07-24 | Wake Forest University Health Sciences | Model system of liver fibrosis and method of making and using the same |
| RU2708329C2 (ru) | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
| EP3824906A1 (en) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| EP3801028A4 (en) | 2018-05-30 | 2022-04-13 | Direct Biologics LLC | A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use |
| CN109628377A (zh) * | 2019-01-02 | 2019-04-16 | 贵州省人民医院 | 一种小鼠原代肝细胞灌注式分离及离体培养方法 |
| CN111607556B (zh) * | 2019-01-25 | 2022-06-07 | 中国科学院广州生物医药与健康研究院 | 一种培养扩增人肝祖细胞的培养基及其应用 |
| IL320107A (en) | 2019-02-07 | 2025-06-01 | Direct Biologics Llc | Method for treating osteoarthritis with a combination of mesenchymal stem cell exosomes, synovial mesencymal stem cells, and scaffolds |
| CA3137785A1 (en) * | 2019-04-30 | 2020-11-05 | Promethera Therapeutics Sa | Preparation of human allogeneic liver-derived progenitor cells |
| CN111394391B (zh) * | 2019-07-11 | 2022-12-06 | 上海赛立维生物科技有限公司 | 肝祖细胞样细胞库的构建方法及其制备的细胞株与应用 |
| WO2021011935A1 (en) | 2019-07-18 | 2021-01-21 | Direct Biologics, Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
| MX2022013301A (es) | 2020-04-22 | 2023-02-14 | Direct Biologics Llc | Métodos y composiciones para tratar las afecciones inflamatorias asociadas con una enfermedad infecciosa. |
| WO2025226276A1 (en) | 2024-04-25 | 2025-10-30 | Direct Biologics, Llc | Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH093099A (ja) * | 1995-06-20 | 1997-01-07 | Toyobo Co Ltd | マクロファージ刺激蛋白質改変体およびその製造法 |
| US6475490B1 (en) * | 1998-10-19 | 2002-11-05 | Fordham University | Compositions and methods for promoting tissue repair using heat shock proteins |
| US6372494B1 (en) | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
| US6719969B1 (en) * | 1999-08-09 | 2004-04-13 | The Regents Of The University Of Michigan | Treatment of liver disease and injury with CXC chemokines |
| CA2290240C (en) | 1999-11-24 | 2008-03-11 | Stergios Stergiopoulos | High resolution 3d ultrasound imaging system deploying a multi-dimensional array of sensors and method for multi-dimensional beamforming sensor signals |
| US7547674B2 (en) * | 2001-06-06 | 2009-06-16 | New York Medical College | Methods and compositions for the repair and/or regeneration of damaged myocardium |
| US6916770B2 (en) | 2001-04-27 | 2005-07-12 | Polyone Corporation | Multi-functional color concentrate compositions |
| WO2002098365A2 (en) * | 2001-06-07 | 2002-12-12 | Skinmedica, Inc. | Conditioned cell culture media and uses thereof |
| US20050053588A1 (en) * | 2001-10-18 | 2005-03-10 | Li Yin | Conversion of liver stem and progenitor cells to pancreatic functional cells |
| WO2006126219A1 (en) * | 2005-05-26 | 2006-11-30 | Fresenius Medical Care Deutschland G.M.B.H. | Liver progenitor cells |
| CA2642664A1 (en) * | 2006-02-16 | 2007-08-30 | Burnham Institute For Medical Research | Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor |
| GEP20135796B (en) * | 2006-03-07 | 2013-04-10 | Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation | |
| FR2912916B1 (fr) * | 2007-02-26 | 2009-05-22 | Oreal | Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire |
-
2009
- 2009-06-11 CN CN200980131229.6A patent/CN102119031B/zh active Active
- 2009-06-11 HU HUE09761761A patent/HUE028676T2/en unknown
- 2009-06-11 JP JP2011512983A patent/JP5632833B2/ja not_active Expired - Fee Related
- 2009-06-11 BR BRPI0909866-6A patent/BRPI0909866B1/pt active IP Right Grant
- 2009-06-11 PL PL09761761T patent/PL2296672T3/pl unknown
- 2009-06-11 DK DK09761761.7T patent/DK2296672T3/en active
- 2009-06-11 ES ES09761761.7T patent/ES2556630T3/es active Active
- 2009-06-11 CA CA2727392A patent/CA2727392C/en active Active
- 2009-06-11 CN CN201310348088.1A patent/CN103800895B/zh active Active
- 2009-06-11 US US12/737,143 patent/US10456425B2/en active Active
- 2009-06-11 WO PCT/EP2009/057232 patent/WO2009150199A1/en not_active Ceased
- 2009-06-11 PT PT97617617T patent/PT2296672E/pt unknown
- 2009-06-11 EP EP09761761.7A patent/EP2296672B1/en active Active
-
2017
- 2017-01-23 US US15/412,142 patent/US10357519B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2928670T3 (es) | Formulación que contiene virus y utilización de la misma | |
| ES2583371T3 (es) | Composiciones, métodos, y dispositivos para tratar enfermedades hepáticas | |
| US20210008106A1 (en) | Mitochondrial treatment of organs for transplantation | |
| Johansson et al. | Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate | |
| JP2023017017A (ja) | 上皮間葉転換を予防または最小限にする方法及び組成物 | |
| Liu et al. | Study on therapeutic action of bone marrow derived mesenchymal stem cell combined with vitamin E against acute kidney injury in rats | |
| JP2023537204A (ja) | 間葉系ストローマ細胞由来の細胞外小胞(ev)および前記evを得るための方法 | |
| CN110177872A (zh) | 间充质干细胞和药物组合物 | |
| JP2023520233A5 (cg-RX-API-DMAC7.html) | ||
| CN107114356A (zh) | 一种胎盘及脐带细胞保护液 | |
| ES2966620T3 (es) | Preparación de células progenitoras hepáticas alogénicas humanas | |
| CN105377275A (zh) | 用于静脉给药的干细胞组合物 | |
| WO2023077160A1 (en) | Methods of treating diseases associated with cellular-energy deficiency or mitochondrial dysfunction by locoregional delivery of extracellular vesicles that have a cargo with an enhanced bioenergetic profile | |
| TW202100170A (zh) | 用於治療慢性肝衰竭之急性發作的成人肝先驅細胞 | |
| TW202035682A (zh) | 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途 | |
| EP3947645A1 (en) | Adult liver progenitor cells for treating non-alcoholic fatty liver disease | |
| Zhou et al. | ROS-responsive diselenide exosomes restores mitophagy to resolve sterile inflammation in liver IRI | |
| EP2175718B1 (en) | Body fluid expanders comprising n-substituted aminosulfonic acid buffers | |
| EP3923965A1 (en) | Methods and compositions for treating viral infections and sequelae thereof | |
| CN107980767B (zh) | 一种长期保存过表达ang-1的epc的保存液 | |
| CN105532646A (zh) | 肝细胞保存液及其制备方法和应用 | |
| CN106474157B (zh) | 一种肝干细胞注射液及其制备方法 | |
| CN103301118A (zh) | 注射用精氨酸布洛芬组合物 | |
| US20170080052A1 (en) | Method of treating fulminant hepatic failure using dll4 cytokine | |
| US20220049225A1 (en) | Cell composition comprising liver progenitor cells expressing hla-e |